Skip to main content
Log in

Factors affecting inter-individual variation in human plasma cholinesterase activity: Body weight, height, sex, genetic polymorphism and age

  • Published:
Archives of Environmental Contamination and Toxicology Aims and scope Submit manuscript

Abstract

The influence of body weight, height, age and sex on plasma cholinesterase activity (ChE) in 650 males and 437 females with ChE-1 phenotype U (genotype ChEuChEu or ChEuChEs) or UA (genotype ChEuChEa) was studied in a multiple regression model. ChE was not influenced by age (p > 0.01), but, like other liver synthesized plasma enzymes, highly (p < 0.001) influenced by body weight and height. In a logarithmic scale ChE followed a linear model (R=0.535, p < 0.001) with randomly distributed residuals, lnChE= 3.286 −0.308 x ChE-1 phenotype −0.104 x sex + 0.00765 x weight −0.00723 x height (U=1, UA=2; male=1, female =2; kg; cm). A simplified model based on body-mass index (BMI = weight divided by squared height, kg/m2), lnCHE=2.016−0.308× ChE-1 phenotype −0.091 x sex + 0.0230 X BMI, showed the same goodness-of-fit (R=0.533). In a non-logarithmic scale both multiple regression models failed to fit cases with high ChE activity. A model for a ‘standardized’ plasma ChE in which the effects of ChE-1 phenotype, sex, body weight and height are eliminated, is proposed to compare ChE in unmatched population groups when using this enzyme activity as a biomarker in environmental or occupational medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Brock A (1988) Plasma cholinesterase genetic variants phenotyped using a cobas-fara centrifugal analyser. J Clin Chem Clin Biochem 26:873–875

    PubMed  Google Scholar 

  • — (1989) Additional electrophoretic components of cholinesterase in plasma: a phenomenon of no importance to the total plasma cholinesterase activity. J Clin Chem Clin Biochem 27:429–431

    PubMed  Google Scholar 

  • — (1990) Immunoreactive plasma cholinesterase (EC 3.1.1.8) substance concentration, compared with cholinesterase activity concentration and albumin: Inter- and intra-individual variations in a healthy population group. J Clin Chem Clin Biochem 28:851–856

    PubMed  Google Scholar 

  • — (1991) Inter and intraindividual variations in plasma cholinesterase activity and substance concentration in employees of an organophosphorus insecticide factory. Brit J Indust Med 48:562–567

    Google Scholar 

  • Brock A, Brock V (1990) Plasma cholinesterase activity in a healthy population group without occupational exposure to known cholinesterase inhibitors: Relative influence of some factors related to normal inter- and intra-individual variations. Scand J Lab Clin Invest 50:401–408

    Google Scholar 

  • Brown SS, Kalow W, Pilz W, Whittaker M, Woronick CL (1981) The plasma cholinesterases: A new perspective. Adv Clin Chem 22:1–123

    PubMed  Google Scholar 

  • Elsie S, King J, Whittaker M (1979) Assay of cholinesterase in clinical chemistry. Ann Clin Biochem 16:57–75

    PubMed  Google Scholar 

  • Fraser CG (1983) Desirable performance standards for clinical chemistry tests. Adv Clin Chem 23:299–339

    PubMed  Google Scholar 

  • — (1988) The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 112:404–415

    PubMed  Google Scholar 

  • Harris EK, Yasaka T (1983) On the calculation of a “reference change” for comparing two consecutive measurements. Clin Chem 29:25–30

    PubMed  Google Scholar 

  • Hetland G, Holme I, Strmme JH (1992) Co-variation of alanine aminotransferase levels with relative weight in blood donors. Scand J Clin Lab Invest 52:51–55

    PubMed  Google Scholar 

  • Hölzel WGE (1987) Intra-individual variation of analytes in serum from patients with chronic liver diseases. Clin Chem 33:1133–1136

    PubMed  Google Scholar 

  • LaDu BN, Bartels CF, Nogueira CP, Hajra A, Lightstone H, Van der Spek A, Lockridge O (1990) Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin Biochem 23:423–431

    PubMed  Google Scholar 

  • LaMotta RV, Woronick CL (1971) Molecular heterogeneity of human serum cholinesterase. Clin Chem 17:135–144

    PubMed  Google Scholar 

  • Lander F, Brock A, Pike E, Hinke K (1992a) Chronic subclinical dietary anticholinesterase uptake from fruits and vegetables in the sprayingseason. Fd Chem Toxic 30:37–40

    Google Scholar 

  • Lander F, Pike E, Hinke K, Brock A, Nielsen JB (1992b) Anticholinesterase agents uptake during cultivation of greenhouse flowers. Arch Environ Cont Toxicol 22:159–162

    Google Scholar 

  • Lepage L, Schiele F, Gueguen R, Siest G (1985) Total cholinesterase in plasma: Biological variations and reference limits. Clin Chem 31:546–550

    PubMed  Google Scholar 

  • Lockridge O (1988) Structure of human serum cholinesterase. Bio-Essays 9:125–128

    Google Scholar 

  • Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE, Johnson LL (1987) Complete amino acid sequence of human serum cholinesterase. J Biol Chem 262:549–557

    PubMed  Google Scholar 

  • McGuire MC, Nogueira CP, Bartels CF, Lightstone H, Hajra A, Van der Spek AFL, Lockridge O, LaDu BN (1989) Identification of the structural mutation responsible for the dibucaineresistant (atypical) variant form of human serum cholinesterase. Proc Natl Acad Sci 86:953–957

    PubMed  Google Scholar 

  • McTiernan C, Adkins S, Shatonnet A, Vaughan TA, Bartels CF, Kott M, Rosenberry TL, LaDu BN, Lockridge O (1987) Brain cDNA clone for human cholinesterase. Proc Natl Acad Sci 84:6682–6686

    PubMed  Google Scholar 

  • Mogensen JV (1983) Cholinesterase and succinylcholine. Dan Med Bull 30:129–150

    PubMed  Google Scholar 

  • Moses GC, Tuckerman JF, Henderson AR (1986) Biological variance of cholinesterase and 5′-nucleotidase in serum of healthy persons. Clin Chem 32:175–177

    PubMed  Google Scholar 

  • National Research Council (1987) Committee Biological Markers. Environ Health Perspc 74:3–9

    Google Scholar 

  • Peakall D (1992) Animal biomarkers as pollution indicators. Chapmann & Hall, London, pp 1–290

    Google Scholar 

  • Rider JA, Hodges JL, Swader J, Wiggins AD (1957) Plasma and red cell cholinesterase in 800 “healthy” blood donors. J Lab Clin Med 50:376–383

    PubMed  Google Scholar 

  • Robinson D, Whitehead TP (1989) Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 26:393–400

    PubMed  Google Scholar 

  • Sidell FR, Kaminskis A (1975) Temporal intrapersonal physiological variability of cholinesterase activity in human plasma and erythrocytes. Clin Chem 21:1961–1963

    PubMed  Google Scholar 

  • Wetstone HJ, LaMotta RV (1965) The Clinical Stability of Serum Cholinesterase Activity. Clin Chem 11:653–663

    PubMed  Google Scholar 

  • Whittaker M (1986) Cholinesterase (Beckman L, ed. Monographs in human genetics; vol. 11). Karger, Basel, pp 1–132

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brock, A., Brock, V. Factors affecting inter-individual variation in human plasma cholinesterase activity: Body weight, height, sex, genetic polymorphism and age. Arch. Environ. Contam. Toxicol. 24, 93–99 (1993). https://doi.org/10.1007/BF01061095

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01061095

Keywords

Navigation